Home › NDC Lookup › RxCUI directory › RxCUI 966768

Atracurium besylate 10 MG/ML Injectable Solution — RxCUI 966768

Name: Atracurium besylate 10 MG/ML Injectable Solution (RxCUI 966768)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 966768 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI966768

Official nameAtracurium besylate 10 MG/ML Injectable Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped5

Package NDCs mapped5

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Atracurium besylate 10 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Atracurium besylate 10 MG/ML Injectable Solution RxCUI 966768 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Atracurium 1218 IN
- Atracurium besylate 1219 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Atracurium Injectable Solution 377156 SCDF
- Atracurium besylate Injectable Solution 2648965 SCDFP
- Atracurium Injectable Product 1154388 SCDG
- Atracurium besylate Injectable Product 2660065 SCDGP
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Atracurium besylate 10 MG/ML 966767 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Atracurium besylate 10 MG/ML SCDC · 966767
Atracurium Injectable Solution SCDF · 377156
Atracurium besylate Injectable Solution SCDFP · 2648965
Atracurium Injectable Product SCDG · 1154388
Atracurium besylate Injectable Product SCDGP · 2660065

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 966768 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00409-1105-02	10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1...	Atracurium Besylate	Hospira, Inc.	2013-05-29
00409-1109-01	10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1109-01) / 5 mL in 1...	Atracurium Besylate	Hospira, Inc.	2013-02-25
55150-0217-10	10 VIAL, MULTI-DOSE in 1 CARTON (55150-217-10) / 10 mL in 1...	Atracurium Besylate	AuroMedics Pharma LLC	2015-04-08
71288-0701-05	10 VIAL, SINGLE-DOSE in 1 CARTON (71288-701-05) / 5 mL in 1...	Atracurium Besylate	Meitheal Pharmaceuticals Inc.	2018-05-15
71288-0702-10	10 VIAL, MULTI-DOSE in 1 CARTON (71288-702-10) / 10 mL in 1...	Atracurium Besylate	Meitheal Pharmaceuticals Inc.	2018-05-15

Observed labelers: Hospira, Inc. (2) · Meitheal Pharmaceuticals Inc. (2) · AuroMedics Pharma LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.